Reviewed by Sarim Mir, MD — Board-Certified Neurologist, Mir Neurology (Hagerstown & Cumberland, MD)
Key takeaways
- This is an evergreen, by-condition guide — jump to the neurological condition that matters most to you.
- Each section gives a short, plain-English summary of where treatment stands in 2026 and an invitation to learn more or book an evaluation.
- We distinguish FDA-approved options from investigational ones still in trials, and we avoid cure claims.
- This page is a starting point, not a substitute for a personalized exam with a board-certified neurologist.
- Patients across Hagerstown, Cumberland, and Western Maryland can request an evaluation with Mir Neurology.
How to use this guide
Neurology moves fast, and headlines rarely explain what a development means for you. This guide is organized by condition rather than by date, so you can go straight to what is relevant. For each condition we summarize the 2026 picture in a few sentences and point you to a deeper conversation. Always confirm what is right for you with your own physician.
Migraine
Migraine care continues to shift from “treat the attack” toward “prevent the attacks.” CGRP-targeted therapies — including monthly or quarterly injections and oral gepants — are well established and FDA-approved for prevention and acute treatment, giving many patients fewer headache days. The 2026 trend is about fit and tolerability: matching the right preventive to your headache pattern, other conditions, and goals. Want fewer migraine days? Learn more on our migraine treatment page or book an evaluation.
Alzheimer’s & Memory
Alzheimer’s treatment has entered the era of disease-modifying therapy. FDA-approved anti-amyloid antibodies can modestly slow decline in early, biomarker-confirmed disease, and 2026 has emphasized easier delivery and broader access alongside careful safety monitoring (including MRI surveillance). These drugs slow progression for selected patients — they are not a cure, and eligibility requires testing. Concerned about memory changes? Learn more about our Alzheimer’s care and memory & cognitive evaluations, or schedule an assessment.
Parkinson’s
For Parkinson’s disease, 2026 advances center on smoother, more continuous symptom control. Newer continuous infusion and extended-delivery formulations of levodopa-based therapy aim to reduce “off” time and motor fluctuations, while deep brain stimulation remains an option for appropriate candidates. The emphasis is on steadier days and individualized device or medication strategies. Struggling with motor fluctuations? Learn more about Parkinson’s disease care and movement disorders, or request an appointment.
Epilepsy
Epilepsy care in 2026 is increasingly precise. Better seizure characterization, expanded options for drug-resistant epilepsy, and neuromodulation devices give more people a path to control when first-line medications fall short. For certain genetic and focal epilepsies, targeted approaches are improving the odds of fewer seizures with fewer side effects. Seizures not fully controlled? Learn more about our epilepsy services and EEG testing, or book an evaluation.
Multiple Sclerosis
MS saw both access and innovation news in 2026. The first complex generic of glatiramer acetate (generic Copaxone) was FDA-approved, which over time may lower costs and ease access for relapsing MS. Meanwhile, a new class — BTK inhibitors — advanced in progressive MS, with one Phase III program meeting its goal and another receiving an FDA Complete Response Letter; these remain investigational for those uses. Living with MS? Learn more about our multiple sclerosis care or schedule a visit.
Peripheral Neuropathy
For peripheral neuropathy, 2026 keeps the focus on finding and treating the cause — diabetes, vitamin deficiencies, autoimmune conditions, and more — alongside better symptom relief. Targeted therapies for specific neuropathies (such as certain hereditary and autoimmune forms) continue to expand, and non-opioid approaches to nerve pain are emphasized. Numbness, tingling, or nerve pain? Learn more about neuropathy treatment and EMG testing, or request an appointment.
Sleep Apnea
Sleep apnea care is broadening beyond CPAP. In 2026, attention has grown around medication-assisted weight reduction for obstructive sleep apnea in selected patients, in addition to established options like CPAP, oral appliances, and surgical or implantable therapies. The right choice depends on your apnea severity, anatomy, and preferences — and proper testing comes first. Snoring, gasping, or daytime fatigue? Learn more about the conditions we treat or book a sleep evaluation.
Stroke
Stroke care continues to reward speed. In 2026, refined clot-busting and clot-removal (thrombectomy) protocols and widening time windows mean more patients can be treated effectively — but only if they arrive in time. Recognizing symptoms early (face drooping, arm weakness, speech difficulty) and calling 911 remains the single most powerful step. Worried about stroke risk? Learn more about stroke & TIA care, or schedule a consultation.
What this means for you in Hagerstown & Cumberland
Whatever brought you to this page, the next step is a conversation tailored to you. Mir Neurology serves patients throughout Western Maryland and can help you separate hype from help — and decide what is appropriate for your situation. Explore our full list of conditions we treat or meet Dr. Sarim Mir, MD.
Call (301) 797-7600 to request an appointment or request an appointment online.
Frequently asked questions
Are all of these 2026 treatments FDA-approved? No. Some are FDA-approved and available now, while others — such as BTK inhibitors for progressive MS — remain investigational and are still in clinical trials. This guide flags the difference, and our team can confirm what is available for your condition.
Does a new treatment mean I should change what I’m doing? Not automatically. If your current plan is working and well tolerated, staying the course may be best. New options are most useful when your symptoms are not controlled or when cost and access have been barriers. We will help you weigh it.
How do I figure out which advance applies to me? Start with an evaluation. The right treatment depends on your diagnosis, test results, other conditions, and goals. Call (301) 797-7600 or request an appointment online, and we will build a plan suited to you.
This guide is for general educational purposes and is not a substitute for individualized medical advice. Treatment decisions should be made with your own physician, and no outcome is guaranteed. FDA-approval status reflects the time of writing and may change.
Sources: Previewing Expected FDA Decisions in Neurology for 2026 (NeurologyLive)
Need to talk to a neurologist about this?
Mir Neurology offers same-week appointments in Hagerstown & Cumberland, MD. No referral needed for most plans.
